| Dr Raymond Seth Sohn, DO | |
|
2124 Kohler Memorial Dr Ste 110, Sheboygan, WI 53081-3174 | |
| (920) 204-6758 | |
| (888) 720-0495 |
| Full Name | Dr Raymond Seth Sohn |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 14 Years |
| Location | 2124 Kohler Memorial Dr Ste 110, Sheboygan, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033430640 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Door County Medical Center | Sturgeon bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wisconsin Spine And Pain Sc | 0345665469 | 14 |
News Archive
Quantum Materials Corp. (OTCQB:QTMM) announced today shipping size-optimized metallic oxide particles to a major Asian electronics conglomerate.
The longstanding idea that the entire human face ages uniformly is in need of a facelift, say researchers at UT Southwestern Medical Center who have found that multiple, distinct compartments of fat in the face age at different rates.
Dr. John Peever at the University of Toronto has been working to answer one of humanity's greatest questions: how do we dream? He has found a certain area of the brain is responsible for this phenomenon and that troubles with normal dreaming may be an early warning sign for ailments such as Parkinson's Disease.
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
› Verified 7 days ago
| Entity Name | Advanced Pain Management Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770506669 PECOS PAC ID: 1456257633 Enrollment ID: O20031209000560 |
News Archive
Quantum Materials Corp. (OTCQB:QTMM) announced today shipping size-optimized metallic oxide particles to a major Asian electronics conglomerate.
The longstanding idea that the entire human face ages uniformly is in need of a facelift, say researchers at UT Southwestern Medical Center who have found that multiple, distinct compartments of fat in the face age at different rates.
Dr. John Peever at the University of Toronto has been working to answer one of humanity's greatest questions: how do we dream? He has found a certain area of the brain is responsible for this phenomenon and that troubles with normal dreaming may be an early warning sign for ailments such as Parkinson's Disease.
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
› Verified 7 days ago
| Entity Name | Wisconsin Spine And Pain Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790309276 PECOS PAC ID: 0345665469 Enrollment ID: O20200806002745 |
News Archive
Quantum Materials Corp. (OTCQB:QTMM) announced today shipping size-optimized metallic oxide particles to a major Asian electronics conglomerate.
The longstanding idea that the entire human face ages uniformly is in need of a facelift, say researchers at UT Southwestern Medical Center who have found that multiple, distinct compartments of fat in the face age at different rates.
Dr. John Peever at the University of Toronto has been working to answer one of humanity's greatest questions: how do we dream? He has found a certain area of the brain is responsible for this phenomenon and that troubles with normal dreaming may be an early warning sign for ailments such as Parkinson's Disease.
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raymond Seth Sohn, DO Dept Ch 17057, Palatine, IL 60055-7057 Ph: (920) 204-6758 | Dr Raymond Seth Sohn, DO 2124 Kohler Memorial Dr Ste 110, Sheboygan, WI 53081-3174 Ph: (920) 204-6758 |
News Archive
Quantum Materials Corp. (OTCQB:QTMM) announced today shipping size-optimized metallic oxide particles to a major Asian electronics conglomerate.
The longstanding idea that the entire human face ages uniformly is in need of a facelift, say researchers at UT Southwestern Medical Center who have found that multiple, distinct compartments of fat in the face age at different rates.
Dr. John Peever at the University of Toronto has been working to answer one of humanity's greatest questions: how do we dream? He has found a certain area of the brain is responsible for this phenomenon and that troubles with normal dreaming may be an early warning sign for ailments such as Parkinson's Disease.
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
› Verified 7 days ago
Dr. Bryan Stuart Wichman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 920-783-1261 | |
Samuel D. Parks, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 608-263-8114 | |
Dr. Joseph S Bernstein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-4700 | |
Daniel R Farber, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 | |
Dr. Joshua R Lacey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 | |
Dr. James S Hoell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 Fax: 920-451-5143 |